1/5ORAMED PHARMACEUTICALS INC. (ORMP): Filing-delay notice, quarterly report filed within extension (NT 10-Q)

Market data

Price before filing: $4.73 (2026-05-14 close, split/dividend-adjusted)
Market cap at flag: $189.2M (2026-05-15) · Latest: $167.0M (2026-10-16)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Verified excerpt

"Oramed Pharmaceuticals Inc. (the "Company") is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the "Form 10-Q"), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q. The Company currently anticipates that the Form 10-Q will be filed on or before the..."

Quoted from the filing. Source

What this means

The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.

Status: filed within extension (report filed 2026-05-19) · the SEC treats a report filed within the extension as timely

Why this score: report filed within the extension on 2026-05-19